progesterone: be prescribed after iui

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.73
, drug
Weight: 0.57
, ingredient
Weight: 0.56
, substance
Weight: 0.55
Siblings estrogen
Weight: 0.39
, glucocorticoid
Weight: 0.39
, oxytocin
Weight: 0.39
, vasopressin
Weight: 0.38
, prolactin
Weight: 0.38

Related properties

Property Similarity
be prescribed after iui 1.00
is prescribed 0.97
be prescribed during pregnancy 0.88
be prescribed in pregnancy 0.88
be prescribed in early pregnancy 0.87
be prescribed during menopause 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.32
Rule weight: 0.66
Evidence weight: 0.51
Similarity weight: 0.97
Evidence: 0.43
Plausible(drug, is prescribed)
Evidence: 0.87
¬ Typical(progesterone, be prescribed after iui)

Plausibility inheritance from parent to child

0.08
Rule weight: 0.09
Evidence weight: 0.94
Similarity weight: 0.97
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.43
¬ Plausible(drug, is prescribed)

Remarkability exclusitivity betweem a parent and a child

0.20
Rule weight: 0.58
Evidence weight: 0.36
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.88
¬ Remarkable(drug, is prescribed)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.48
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.71
¬ Remarkable(oxytocin, is prescribed)
0.05
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.82
¬ Remarkable(estrogen, is prescribed)

Remarkability from parent implausibility

0.35
Rule weight: 0.42
Evidence weight: 0.87
Similarity weight: 0.97
Evidence: 0.43
Plausible(drug, is prescribed)
Evidence: 0.73
Remarkable(progesterone, be prescribed after iui)
Evidence: 0.86
¬ Plausible(progesterone, be prescribed after iui)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.97
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.82
Remarkable(estrogen, is prescribed)
Evidence: 0.56
¬ Plausible(estrogen, is prescribed)
0.57
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.97
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.71
Remarkable(oxytocin, is prescribed)
Evidence: 0.54
¬ Plausible(oxytocin, is prescribed)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.95
¬ Salient(progesterone, be prescribed after iui)

Similarity expansion

0.80
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.97
Evidence: 0.87
Typical(progesterone, be prescribed after iui)
Evidence: 0.26
¬ Typical(progesterone, is prescribed)
0.80
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.97
Evidence: 0.95
Salient(progesterone, be prescribed after iui)
Evidence: 0.67
¬ Salient(progesterone, is prescribed)
0.77
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.97
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.44
¬ Plausible(progesterone, is prescribed)
0.72
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.88
Evidence: 0.95
Salient(progesterone, be prescribed after iui)
Evidence: 0.82
¬ Salient(progesterone, be prescribed during pregnancy)
0.72
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.88
Evidence: 0.95
Salient(progesterone, be prescribed after iui)
Evidence: 0.85
¬ Salient(progesterone, be prescribed in pregnancy)
...

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.95
Salient(progesterone, be prescribed after iui)
Evidence: 0.87
¬ Typical(progesterone, be prescribed after iui)
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.86
Plausible(progesterone, be prescribed after iui)
Evidence: 0.87
¬ Typical(progesterone, be prescribed after iui)

Typicality and Rermarkability incompatibility between a parent and a child

0.38
Rule weight: 0.51
Evidence weight: 0.77
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.31
¬ Typical(drug, is prescribed)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.66
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.47
¬ Typical(estrogen, is prescribed)
0.08
Rule weight: 0.14
Evidence weight: 0.62
Similarity weight: 0.97
Evidence: 0.73
¬ Remarkable(progesterone, be prescribed after iui)
Evidence: 0.52
¬ Typical(oxytocin, is prescribed)

Typicality inheritance from parent to child

0.45
Rule weight: 0.48
Evidence weight: 0.96
Similarity weight: 0.97
Evidence: 0.87
Typical(progesterone, be prescribed after iui)
Evidence: 0.31
¬ Typical(drug, is prescribed)